Delivery of gefitinib in synergism with thymoquinone via transferrin-conjugated nanoparticle sensitizes gefitinib-resistant non-small cell lung carcinoma to control metastasis and stemness

Priyanka Upadhyay, Avijit Ghosh, Arijita Basu, P. A. Pranati, Payal Gupta, Shaswati Das, Sushmita Sarker, Mousumi Bhattacharjee, Saurav Bhattacharya, Swatilekha Ghosh, Sreya Chattopadhyay and Arghya Adhikary

Biomater. Sci., 2021, 9, 8285
DOI: 10.1039/D1BM01148K

Delivery of novel coumarin–dihydropyrimidinone conjugates through mixed polymeric nanoparticles to potentiate therapeutic efficacy against triple-negative breast cancer

Avijit Ghosh, Priyanka Upadhyay, Sushmita Sarker, Shaswati Das, Mousumi Bhattacharjee, Saurav Bhattacharya, Manisha Ahir, Subhajit Guria, Payal Gupta, Sreya Chattopadhyay, Swatilekha Ghosh, Susanta Adhikari and Arghya Adhikary

Biomater. Sci., 2021, 9, 5665
DOI: 10.1039/D1BM00424G

Engineered mesoporous silica nanoparticles, new insight nanoplatforms into effective cancer gene therapy

Razieh Heidari, Vahideh Assadollahi, Pegah Khosravian, Seyed Abbas Mirzaei and Fatemeh Elahian

International Journal of Biological Macromolecules, 2023, 253, 127060
DOI: 10.1016/j.ijbiomac.2023.127060

A Systematic Review to Clarify the Prognostic Values of CD44 and CD44+CD24- Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead

Mahdi Abdoli Shadbad, Negar Hosseinkhani, Zahra Asadzadeh, Afshin Derakhshani, Noora Karim Ahangar, Nima Hemmat, Parisa Lotfinejad, Oronzo Brunetti, Nicola Silvestris and Behzad Baradaran

Front. Oncol., 2021, 11
DOI: 10.3389/fonc.2021.689839

Targeted Delivery of Metformin Against Lung Cancer Cells Via Hyaluronan-Modified Mesoporous Silica Nanoparticles

Fan Zhang, Wei Liu, Yonggui Long and Huali Peng

Appl Biochem Biotechnol, 2023, 195, 4067
DOI: 10.1007/s12010-022-04289-6

Recent Applications of Mesoporous Silica Nanoparticles in Gene Therapy

Tamanna Binte Huq, Punnya Anil Kumar Jeeja, Sudip Kumar Dam, Sabya Sachi Das and Juan L. Vivero‐Escoto

Adv Healthcare Materials, 2025
DOI: 10.1002/adhm.202404781

Mesoporous Silica Nanoparticles for Potential Immunotherapy of Hepatocellular Carcinoma

Han Wu, Xin-Fei Xu, Jia-Qi Zhu, Ming-Da Wang, Chao Li, Lei Liang, Hao Xing, Meng-Chao Wu, Feng Shen, Dong-Sheng Huang and Tian Yang

Front. Bioeng. Biotechnol., 2021, 9
DOI: 10.3389/fbioe.2021.695635

Harnessing the power of inorganic nanoparticles for the management of TNBC

Biswajit Rout, Prashant Ambadas Janjal, Rushikesh Sanjay Shewale, Vasu Peddinti, Tejas Girish Agnihotri, Shyam Sudhakar Gomte and Aakanchha Jain

International Journal of Pharmaceutics, 2025, 672, 125333
DOI: 10.1016/j.ijpharm.2025.125333

Recent advances of polymer based nanosystems in cancer management

Chetan Janrao, Shivani Khopade, Akshay Bavaskar, Shyam Sudhakar Gomte, Tejas Girish Agnihotri and Aakanchha Jain

Journal of Biomaterials Science, Polymer Edition, 2023, 34, 1274
DOI: 10.1080/09205063.2022.2161780

Delivery of Therapeutic Biopolymers Employing Silica-Based Nanosystems

Zoila Gándara, Noelia Rubio and Rafael R. Castillo

Pharmaceutics, 2023, 15, 351
DOI: 10.3390/pharmaceutics15020351

Glycans as Targets for Drug Delivery in Cancer

Francisca Diniz, Pedro Coelho, Henrique O. Duarte, Bruno Sarmento, Celso A. Reis and Joana Gomes

Cancers, 2022, 14, 911
DOI: 10.3390/cancers14040911

Validation of Dual-Action Chemo-Radio-Labeled Nanocarriers with High Efficacy against Triple-Negative Breast Cancer

Shaista Ilyas, Sabri E. M. Sahnoun, Annika Szymura, Jonas Pes, Shahin Habib, Alexandru Florea, Laura Schäfer, Eva Miriam Buhl, Agnieszka Morgenroth, Pardes Habib, Felix M. Mottaghy and Sanjay Mathur

ACS Appl. Mater. Interfaces, 2023, 15, 48963
DOI: 10.1021/acsami.3c10579

Recent advances in novel miRNA mediated approaches for targeting breast cancer

Seyedeh Melika Ahmadi, Shervin Amirkhanloo, Rezvan Yazdian-Robati, Hossein Ebrahimi, Faezeh Hosseini Pirhayati, Waleed H. Almalki, Pedram Ebrahimnejad and Prashant Kesharwani

Journal of Drug Targeting, 2023, 31, 777
DOI: 10.1080/1061186X.2023.2240979

Hyaluronic acid engrafted metformin loaded graphene oxide nanoparticle as CD44 targeted anti-cancer therapy for triple negative breast cancer

Arijita Basu, Priyanka Upadhyay, Avijit Ghosh, Aparajita Bose, Payal Gupta, Sreya Chattopadhyay, Dipankar Chattopadhyay and Arghya Adhikary

Biochimica et Biophysica Acta (BBA) - General Subjects, 2021, 1865, 129841
DOI: 10.1016/j.bbagen.2020.129841

Role of microRNA alternation in the pathogenesis of gouty arthritis

Zhipan Luo, Fan Yang, Shaocheng Hong, Jianpeng Wang, Bangjie Chen, Liangyun Li, Junfa Yang, Yan Yao, Chenchen Yang, Ying Hu, Shuxian Wang, Tao Xu and Jun Wu

Front. Endocrinol., 2022, 13
DOI: 10.3389/fendo.2022.967769

Role of adhesion molecules in cancer and targeted therapy

Chunmei Fan, Fang Xiong, Shanshan Zhang, Zhaojian Gong, Qianjin Liao, Guiyuan Li, Can Guo, Wei Xiong, He Huang and Zhaoyang Zeng

Sci. China Life Sci., 2024, 67, 940
DOI: 10.1007/s11427-023-2417-3

Therapeutic Delivery of Tumor Suppressor miRNAs for Breast Cancer Treatment

Sonali S. Shinde, Sakeel Ahmed, Jonaid Ahmad Malik, Umme Hani, Afreen Khanam, Faisal Ashraf Bhat, Suhail Ahmad Mir, Mohammed Ghazwani, Shadma Wahab, Nazima Haider and Abdulrahman A. Almehizia

Biology, 2023, 12, 467
DOI: 10.3390/biology12030467

Recent Advances in Targeted Nanocarriers for the Management of Triple Negative Breast Cancer

Rajesh Pradhan, Anuradha Dey, Rajeev Taliyan, Anu Puri, Sanskruti Kharavtekar and Sunil Kumar Dubey

Pharmaceutics, 2023, 15, 246
DOI: 10.3390/pharmaceutics15010246

A Narrative Review of Current Advances and Future Changes Regarding Bladder Cancer Treatment

Dominik Godlewski, Sara Czech, Jakub Szpara, Dorota Bartusik-Aebisher and David Aebisher

Uro, 2025, 5, 11
DOI: 10.3390/uro5020011

Harnessing natural compounds to modulate miRNAs in breast cancer therapy

Shaza H. Aly, Ahmed I. Abulsoud, Yasser M. Moustafa, Sherif S. Abdel Mageed, Nourhan M. Abdelmaksoud, Walaa A. El-Dakroury, Osama A. Mohammed, Mustafa Ahmed Abdel-Reheim, Mohamed Bakr Zaki, Nehal I. Rizk, Ahmed Elshafei, Hanan Elimam, Alaa Ashraf and Ahmed S. Doghish

Funct Integr Genomics, 2024, 24
DOI: 10.1007/s10142-024-01489-7

MicroRNAs in Cancer Immunology: Master Regulators of the Tumor Microenvironment and Immune Evasion, with Therapeutic Potential

Erfan Zare, Seyyed Mohammad Yaghoubi, Maedeh Khoshnazar, Sina Jafari Dargahlou, Janvhi Suresh Machhar, Zihan Zheng, Pascal H. G. Duijf and Behzad Mansoori

Cancers, 2025, 17, 2172
DOI: 10.3390/cancers17132172

Applications and developments of gene therapy drug delivery systems for genetic diseases

Xiuhua Pan, Hanitrarimalala Veroniaina, Nan Su, Kang Sha, Fenglin Jiang, Zhenghong Wu and Xiaole Qi

Asian Journal of Pharmaceutical Sciences, 2021, 16, 687
DOI: 10.1016/j.ajps.2021.05.003

RGD-Coated Polymer Nanoworms for Enriching Cancer Stem Cells

Yushu Gu, Valentin Bobrin, Dayong Zhang, Bing Sun, Chun Ki Ng, Sung-Po R. Chen, Wenyi Gu and Michael J. Monteiro

Cancers, 2022, 15, 234
DOI: 10.3390/cancers15010234

Research progress on non-protein-targeted drugs for cancer therapy

Yiwen Zhang, Lu Lu, Feifeng Song, Xiaozhou Zou, Yujia Liu, Xiaowei Zheng, Jinjun Qian, Chunyan Gu, Ping Huang and Ye Yang

J Exp Clin Cancer Res, 2023, 42
DOI: 10.1186/s13046-023-02635-y

PLGA-based drug delivery system for combined therapy of cancer: research progress

Zhang Ruirui, Jian He, Ximei Xu, Shengxian Li, Hongmei Peng, Zhiming Deng and Yong Huang

Mater. Res. Express, 2021, 8, 122002
DOI: 10.1088/2053-1591/ac3f5e

Role of Nano-miRNAs in Diagnostics and Therapeutics

Donatella Coradduzza, Emanuela Bellu, Antonella Congiargiu, Aleksei Pashchenko, Evzen Amler, Alois Necas, Ciriaco Carru, Serenella Medici and Margherita Maioli

IJMS, 2022, 23, 6836
DOI: 10.3390/ijms23126836

MicroRNAs in T Cell-Immunotherapy

Sara G. Dosil, Ana Rodríguez-Galán, Francisco Sánchez-Madrid and Lola Fernández-Messina

IJMS, 2022, 24, 250
DOI: 10.3390/ijms24010250

The Features of Immune Checkpoint Gene Regulation by microRNA in Cancer

Fatimat Kipkeeva, Tatyana Muzaffarova, Alexandra Korotaeva, Danzan Mansorunov, Pavel Apanovich, Maxim Nikulin, Olga Malikhova, Ivan Stilidi and Alexander Karpukhin

IJMS, 2022, 23, 9324
DOI: 10.3390/ijms23169324

Clinical value and potential mechanisms of COL8A1 upregulation in breast cancer: a comprehensive analysis

Wei Peng, Jian-Di Li, Jing-Jing Zeng, Xiao-Ping Zou, Deng Tang, Wei Tang, Min-Hua Rong, Ying Li, Wen-Bin Dai, Zhong-Qing Tang, Zhen-Bo Feng and Gang Chen

Cancer Cell Int, 2020, 20
DOI: 10.1186/s12935-020-01465-8

MEF2C and miR-194-5p: New Players in Triple Negative Breast Cancer Tumorigenesis

Sara Caetano, Ana Rita Garcia, Inês Figueira and Maria Alexandra Brito

IJMS, 2023, 24, 14297
DOI: 10.3390/ijms241814297

Natural compounds as regulators of miRNAs: exploring a new avenue for treating brain cancer

Ahmed S. Doghish, Walaa A. El-Dakroury, Ahmed I. Abulsoud, Nourhan M. Abdelmaksoud, Shaza H. Aly, Abdullah M. M. Elbadry, Osama A. Mohammed, Mustafa Ahmed Abdel-Reheim, Mohamed Bakr Zaki, Nehal I. Rizk, Esraa M. Mosalam, Amany S. EL-Khouly and Sherif S. Abdel Mageed

Naunyn-Schmiedeberg's Arch Pharmacol, 2025, 398, 9551
DOI: 10.1007/s00210-025-03934-1

Novel Strategies Using Sagacious Targeting for Site-Specific Drug Delivery in Breast Cancer Treatment: Clinical Potential and Applications

Pedram Ebrahimnejad, Zahra Mohammadi, Amirhossein Babaei, Melika Ahmadi, Shervin Amirkhanloo, Kofi Asare-Addo and Ali Nokhodchid

Crit Rev Ther Drug Carrier Syst, 2024, 41, 35
DOI: 10.1615/CritRevTherDrugCarrierSyst.v41.i1.20

Epigenetic remodeling under oxidative stress: Mechanisms driving tumor metastasis

Peilan Peng, Siyuan Qin, Lei Li, Zhijun He, Bowen Li, Edouard C. Nice, Li Zhou and Yunlong Lei

MedComm – Oncology, 2024, 3
DOI: 10.1002/mog2.70000

Nanotechnology‐Assisted RNA Delivery: From Nucleic Acid Therapeutics to COVID‐19 Vaccines

Chiara Rinoldi, Seyed Shahrooz Zargarian, Pawel Nakielski, Xiaoran Li, Anna Liguori, Francesca Petronella, Dario Presutti, Qiusheng Wang, Marco Costantini, Luciano De Sio, Chiara Gualandi, Bin Ding and Filippo Pierini

Small Methods, 2021, 5
DOI: 10.1002/smtd.202100402

Emerging innovations on exosome-based onco-therapeutics

Xiaofeng Dai, Yongju Ye and Fule He

Front. Immunol., 2022, 13
DOI: 10.3389/fimmu.2022.865245

Silica-Based Gene Delivery Systems: From Design to Therapeutic Applications

Ana Maria Carvalho, Rosemeyre A. Cordeiro and Henrique Faneca

Pharmaceutics, 2020, 12, 649
DOI: 10.3390/pharmaceutics12070649

Mesoporous Silica Nanoparticles for Co-Delivery of Drugs and Nucleic Acids in Oncology: A Review

Juan L. Paris and María Vallet-Regí

Pharmaceutics, 2020, 12, 526
DOI: 10.3390/pharmaceutics12060526

A bird's eye view of the advanced approaches and strategies for overshadowing triple negative breast cancer

Nilesh Malavia, Kaushik Kuche, Rohan Ghadi and Sanyog Jain

Journal of Controlled Release, 2021, 330, 72
DOI: 10.1016/j.jconrel.2020.12.012

Ligand-Mediated Nanomedicines Against Breast Cancer: A Review

Guilherme F Picheth, Fernando A de O Ganzella, João OC Filizzola, Yan K Canquerino, Gabriela C Cardoso, Michelle B Collini, Leonardo B Colauto, Maria Cristina Figueroa-Magalhães, Edneia ASR Cavalieri and Giseli Klassen

Nanomedicine (Lond.), 2022, 17, 645
DOI: 10.2217/nnm-2021-0473

Mesoporous Silica Nanoparticles as Carriers for Therapeutic Biomolecules

Rafael R. Castillo, Daniel Lozano and María Vallet-Regí

Pharmaceutics, 2020, 12, 432
DOI: 10.3390/pharmaceutics12050432

Nanomedicine in Bladder Cancer Therapy

Adrianna Winnicka, Joanna Brzeszczyńska, Joanna Saluk and Paulina Wigner-Jeziorska

IJMS, 2024, 25, 10388
DOI: 10.3390/ijms251910388

Facile fabrication of hypercrosslinked microporous polymer nanospheres for effective inhibition of triple negative breast cancer cells proliferation

Shumaila Razzaque, Lijuan Guo, Jun Weng, Li Su and Bien Tan

Journal of Colloid and Interface Science, 2022, 620, 94
DOI: 10.1016/j.jcis.2022.03.109

Non-coding RNAs and potential therapeutic targeting in cancer

Shusuke Toden, Timothy J. Zumwalt and Ajay Goel

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2021, 1875, 188491
DOI: 10.1016/j.bbcan.2020.188491

Recent Advances of Multifunctional PLGA Nanocarriers in the Management of Triple-Negative Breast Cancer

Yirivinti Hayagreeva Dinakar, Naveen Rajana, Nalla Usha Kumari, Vikas Jain and Neelesh Kumar Mehra

AAPS PharmSciTech, 2023, 24
DOI: 10.1208/s12249-023-02712-7

An Update on Mesoporous Silica Nanoparticle Applications in Nanomedicine

Elham Rastegari, Yu-Jer Hsiao, Wei-Yi Lai, Yun-Hsien Lai, Tien-Chun Yang, Shih-Jen Chen, Pin-I Huang, Shih-Hwa Chiou, Chung-Yuan Mou and Yueh Chien

Pharmaceutics, 2021, 13, 1067
DOI: 10.3390/pharmaceutics13071067

miR-10b as a Clinical Marker and a Therapeutic Target for Metastatic Breast Cancer

Alan Halim, Bryan Kim, Elizabeth Kenyon and Anna Moore

Technol Cancer Res Treat, 2025, 24
DOI: 10.1177/15330338251339256

Polymeric functionalization of mesoporous silica nanoparticles: Biomedical insights

Akhil Nair, Raghu Chandrashekhar H., Candace M. Day, Sanjay Garg, Yogendra Nayak, Padmaja A. Shenoy and Usha Y Nayak

International Journal of Pharmaceutics, 2024, 660, 124314
DOI: 10.1016/j.ijpharm.2024.124314

Recent Advances in Mesoporous Silica Nanoparticle-Based Targeted Drug-Delivery Systems for Cancer Therapy

Ying Li, Guoxing Deng, Xianlong Hu, Chenyang Li, Xiaodong Wang, Qinchang Zhu, Kai Zheng, Wei Xiong and Haiqiang Wu

Nanomedicine (Lond.), 2022, 17, 1253
DOI: 10.2217/nnm-2022-0023

Unveiling Role of MicroRNAs in Metastasizing Triple Negative Breast Cancer: From Therapeutics to Delivery

Acharya Balkrishna, Rashmi Mittal and Vedpriya Arya

CDT, 2023, 24, 509
DOI: 10.2174/1389450124666230308154551

Lipoplexes for effective in vitro delivery of microRNAs to adult human cardiac fibroblasts for perspective direct cardiac cell reprogramming

Letizia Nicoletti, Camilla Paoletti, Giulia Tarricone, Ilaria Andreana, Barbara Stella, Silvia Arpicco, Carla Divieto, Clara Mattu and Valeria Chiono

Nanomedicine: Nanotechnology, Biology and Medicine, 2022, 45, 102589
DOI: 10.1016/j.nano.2022.102589

Advances in Understanding Mitochondrial MicroRNAs (mitomiRs) on the Pathogenesis of Triple‐Negative Breast Cancer (TNBC)

Hung-Yu Lin, Pei-Yi Chu and Kanhaiya Singh

Oxidative Medicine and Cellular Longevity, 2021, 2021
DOI: 10.1155/2021/5517777

Targeting and engineering biomarkers for prostate cancer therapy

Dhirodatta Senapati, Santosh Kumar Sahoo, Bhabani Shankar Nayak, Satyanarayan Senapati, Gopal C. Kundu and Subrat Kumar Bhattamisra

Molecular Aspects of Medicine, 2025, 103, 101359
DOI: 10.1016/j.mam.2025.101359

Nano-vehicles modulated delivery of therapeutic epigenetic regulators to treat Triple-Negative Breast Cancer

Elda A. Flores-Contreras, Reyna Berenice González-González, Everardo González-González, Roberto Parra-Saldívar and Hafiz M.N. Iqbal

Journal of Drug Delivery Science and Technology, 2022, 77, 103924
DOI: 10.1016/j.jddst.2022.103924

Molecular insights and novel approaches for targeting tumor metastasis

Sabya Sachi Das, Saad Alkahtani, Priyanshu Bharadwaj, Mohammed Tahir Ansari, Muneera D.F. ALKahtani, Zhiqing Pang, Md Saquib Hasnain, Amit Kumar Nayak and Tejraj M. Aminabhavi

International Journal of Pharmaceutics, 2020, 585, 119556
DOI: 10.1016/j.ijpharm.2020.119556

A Bird’s Eye View of Various Cell-Based Biomimetic Nanomedicines for the Treatment of Arthritis

Nupur Vasdev, Bhakti Pawar, Tanisha Gupta, Mahi Mhatre and Rakesh Kumar Tekade

Pharmaceutics, 2023, 15, 1150
DOI: 10.3390/pharmaceutics15041150

Next-generation miRNA therapeutics: from computational design to translational engineering

Dilpreet Singh

Naunyn-Schmiedeberg's Arch Pharmacol, 2025
DOI: 10.1007/s00210-025-04521-0

Mesoporous Silica-Based Nanoplatforms Are Theranostic Agents for the Treatment of Inflammatory Disorders

Bhagavathi Sivamaruthi, Subramanian Thangaleela, Periyanaina Kesika, Natarajan Suganthy and Chaiyavat Chaiyasut

Pharmaceutics, 2023, 15, 439
DOI: 10.3390/pharmaceutics15020439

Applications of nanotechnologies for miRNA-based cancer therapeutics: current advances and future perspectives

Luis Alberto Bravo-Vázquez, Andrea Méndez-García, Alma L. Rodríguez, Padmavati Sahare, Surajit Pathak, Antara Banerjee, Asim K. Duttaroy and Sujay Paul

Front. Bioeng. Biotechnol., 2023, 11
DOI: 10.3389/fbioe.2023.1208547

Role of CD44-Positive Extracellular Vesicles Derived from Highly Metastatic Mouse Mammary Carcinoma Cells in Pre-Metastatic Niche Formation

Ayana Ikari, Yuko Ito, Kohei Taniguchi, Masa-Aki Shibata, Kosei Kimura, Mitsuhiko Iwamoto and Sang-Woong Lee

IJMS, 2024, 25, 9742
DOI: 10.3390/ijms25179742

Chitosan oligosaccharide decorated liposomes combined with TH302 for photodynamic therapy in triple negative breast cancer

Yinan Ding, Rui Yang, Weiping Yu, Chunmei Hu, Zhiyuan Zhang, Dongfang Liu, Yanli An, Xihui Wang, Chen He, Peidang Liu, Qiusha Tang and Daozhen Chen

J Nanobiotechnol, 2021, 19
DOI: 10.1186/s12951-021-00891-8

Nanomedicine mediated thyroid cancer diagnosis and treatment: an approach from generalized to personalized medicine

Deepak Gulwani, Priyanka Upadhyay, Ridhima Goel, Vijaya Sarangthem and Thoudam Debraj Singh

Discov Onc, 2024, 15
DOI: 10.1007/s12672-024-01677-8

InflammamiRs in focus: Delivery strategies and therapeutic approaches

Yeliz Z. Akkaya‐Ulum, Basak Sen, Tayfun Hilmi Akbaba and Banu Balci‐Peynircioglu

The FASEB Journal, 2024, 38
DOI: 10.1096/fj.202302028R

Nanoparticle mediated RNA delivery for wound healing

Elayaraja Kolanthai, Yifei Fu, Udit Kumar, Balaashwin Babu, Architha Krishnammal Venkatesan, Kenneth W. Liechty and Sudipta Seal

WIREs Nanomed Nanobiotechnol, 2022, 14
DOI: 10.1002/wnan.1741

Nanoengineered oncolytic virus-mimicking dendrimer to synergize with interference RNA to induce immunogenic cell death and up regulation of “find-me” signals

Kannaiyakumar Dharshini, Sivaraj Mehnath, Gnanasekar Sathishkumar, Ammavasi Chandran Ambigaibalan and Murugaraj Jeyaraj

Journal of Drug Delivery Science and Technology, 2025, 107, 106810
DOI: 10.1016/j.jddst.2025.106810

A panel of miRNAs as prognostic markers for African-American patients with triple negative breast cancer

Safaa Turkistani, Bruna M. Sugita, Paolo Fadda, Rafael Marchi, Ali Afsari, Tammey Naab, Victor Apprey, Robert L. Copeland, Michael C. Campbell, Luciane R. Cavalli and Yasmine Kanaan

BMC Cancer, 2021, 21
DOI: 10.1186/s12885-021-08573-2

Polymer‐Initiating Caveolae‐Mediated Endocytosis and GSH‐Responsive MiR‐34a Gene Delivery System for Enhanced Orthotopic Triple Negative Breast Cancer Therapy

Tian‐Yan Han, Meng‐Lei Huan, Zedong Cai, Wei He, Si‐Yuan Zhou and Bang‐Le Zhang

Adv Healthcare Materials, 2023, 12
DOI: 10.1002/adhm.202302094

Role of miRNAs in breast cancer development and progression: Current research

Sachin Kumar and Abhishek Ranga

BioFactors, 2025, 51
DOI: 10.1002/biof.2146

Emergence of Nanoscale Drug Carriers through Supramolecular Self-Assembly of RNA with Calixarene

Ruslan Kashapov, Yuliya Razuvayeva, Nadezda Kashapova, Albina Ziganshina, Vadim Salnikov, Anastasiia Sapunova, Alexandra Voloshina and Lucia Zakharova

IJMS, 2023, 24, 7911
DOI: 10.3390/ijms24097911

MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways

Arefeh Zabeti Touchaei and Sogand Vahidi

Cancer Cell Int, 2024, 24
DOI: 10.1186/s12935-024-03293-6

Systemic Codelivery of Thymoquinone and Doxorubicin by Targeted Mesoporous Silica Nanoparticle Sensitizes Doxorubicin-Resistant Breast Cancer by Interfering between the MDR1/P-gp and miR 298 Crosstalk

Mousumi Bhattacharjee, Avijit Ghosh, Shaswati Das, Sushmita Sarker, Saurav Bhattacharya, Ankur Das, Subhajit Ghosh, Sreya Chattopadhyay, Swatilekha Ghosh and Arghya Adhikary

ACS Biomater. Sci. Eng., 2024, 10, 6314
DOI: 10.1021/acsbiomaterials.4c01081